A medical professional will train you in the injection process so that you can ... often as intramuscular or subcutaneous medications. Ocrelizumab (Ocrevus) is the only FDA-approved medication ...

The phase 3 OCARINA II trial showed that a 10-minute injection with Ocrevus (ocrelizumab) was able to maintain levels of the drug in the blood, as well as IV administration over a 12-week period ...

Approved in Europe earlier this month, Ocrevus (ocrelizumab) offers a new treatment option for patients with relapsing disease. It is also the first drug approved for patients with primary ...

Moran and colleagues suggest a 2-week treatment of daily injection of the LifeSite valve pocket with 70% IPA in addition to appropriate systemic antibiotics. [18] If cultures repeated 1 week after ...

Halozyme Therapeutics, Inc., a biopharmaceutical company, researches, develops, and commercializes of proprietary enzymes and devices in the United States and internationally. The company’s ...

Botox (onabotulinumtoxinA) is an injection prescribed for various conditions, including chronic (long-term) migraine, overactive bladder, and some muscle conditions. Botox has a boxed warning.

You use the pen to inject the solution under your skin. You can give the injection in your abdomen or the front of your thigh. (A caregiver can also give you an injection in the back of your upper ...

In 2017, the U.S. Food and Drug Administration (FDA) approved ocrelizumab (Ocrevus) to treat adults who have relapsing forms of multiple sclerosis and primary-progressive multiple sclerosis (PPMS).